• All
  • Acquisitions
  • Events
  • Executive Search
  • Finance
  • News
  • Press Releases
  • Uncategorized
  • Views

Royal Biologics' Cryo-Cord™, Amnio-Maxx™, Amnio-Maxx™ Lite and Derm-Maxx™ Receive High-Tier Reimbursement in the Hospital Outpatient Departments and Reimbursement in the Physician Office to Treat Chronic Non-Healing Wounds HACKENSACK, N.J., February 15,...

DURHAM, NC – February 4, 2021 – Bioventus Inc. (“Bioventus” or the “Company”), today announced that it has commenced the initial public offering of its Class A common stock. Bioventus is offering...